相似文献
1
Primary care diagnostic technology update: point-of-care testing for glycosylated haemoglobin.基础医疗诊断技术更新：即时检验糖化血红蛋白。
Br J Gen Pract. 2011 Feb;61(583):139-40. doi: 10.3399/bjgp11X556290.
2
Serum glycated albumin to haemoglobin A(1C) ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus.糖化血清白蛋白与血红蛋白 A1c 的比值可用于区分暴发性 1 型糖尿病与 2 型糖尿病。
Ann Clin Biochem. 2010 Jul;47(Pt 4):313-7. doi: 10.1258/acb.2010.009234. Epub 2010 Jun 1.
3
Point-of-care blood test for ketones in patients with diabetes: primary care diagnostic technology update.糖尿病患者酮体的即时检验：基层医疗诊断技术更新
Br J Gen Pract. 2011 Aug;61(589):530-1. doi: 10.3399/bjgp11X588600.
4
Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.澳大利亚偏远原住民社区中糖化血红蛋白（HbA1c）和血糖的即时检测
Med J Aust. 2005 May 16;182(10):524-7. doi: 10.5694/j.1326-5377.2005.tb00019.x.
5
[On the possibility of postmortem diagnosis of diabetes mellitus].[关于糖尿病死后诊断的可能性]
Sud Med Ekspert. 2010 Sep-Oct;53(5):39-40.
6
Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis.糖化血红蛋白与糖尿病充血性心力衰竭风险的关系：系统评价和荟萃分析。
Eur J Heart Fail. 2013 Feb;15(2):185-93. doi: 10.1093/eurjhf/hfs156. Epub 2012 Oct 25.
7
Using haemoglobin A(1c) to diagnose type 2 diabetes or to identify people at high risk of diabetes.使用糖化血红蛋白A（1c）诊断2型糖尿病或识别糖尿病高危人群。
BMJ. 2014 Apr 25;348:g2867. doi: 10.1136/bmj.g2867.
8
Changes in levels of haemoglobin A1c during the first 6 years after diagnosis of clinical type 2 diabetes.诊断为临床 2 型糖尿病后 6 年内的血红蛋白 A1c 水平变化。
Scand J Clin Lab Invest. 2009;69(8):851-7. doi: 10.3109/00365510903323191.
9
High-normal HbA1c is a strong predictor of type 2 diabetes in the general population.高正常 HbA1c 是一般人群 2 型糖尿病的强有力预测指标。
Diabetes Care. 2011 Apr;34(4):1038-40. doi: 10.2337/dc10-1180. Epub 2011 Feb 9.
10
Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials.基线 HbA1c 与当前降糖治疗疗效的关系：一项随机临床试验的荟萃分析。
Diabet Med. 2010 Mar;27(3):309-17. doi: 10.1111/j.1464-5491.2010.02941.x.
引用本文的文献
1
Primary Technology Enhanced Care Home HbA1c Testing (PTEC HAT) programme: a feasibility pilot study in Singapore.基层技术强化护理院糖化血红蛋白检测（PTEC HAT）项目：新加坡的一项可行性试点研究。
BMC Prim Care. 2024 Apr 23;25(1):127. doi: 10.1186/s12875-024-02373-w.
2
Last Trends in Point-of-Care (POC) Diagnostics for the Management of Hematological Indices in Home Care Patients.居家患者血液学指标的即时检验（POC）诊断管理的最新趋势。
Biosensors (Basel). 2023 Mar 4;13(3):345. doi: 10.3390/bios13030345.
3
Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent.拉丁美洲糖尿病患病率、知晓率、治疗率和控制率的现状：改善全洲健康结局所面临的挑战和创新性解决方案。
Curr Diab Rep. 2020 Oct 10;20(11):62. doi: 10.1007/s11892-020-01341-9.
4
Impact of Monthly A1C Values Obtained at Home on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.在家中每月测得的糖化血红蛋白（A1C）值对2型糖尿病患者血糖控制的影响：一项随机临床试验
Clin Diabetes. 2020 Jul;38(3):230-239. doi: 10.2337/cd19-0086.
5
Opportunities and challenges of a novel cardiac output response to stress (CORS) test to enhance diagnosis of heart failure in primary care: qualitative study.新型心力应激反应（CORS）试验增强初级保健中心心力衰竭诊断的机遇与挑战：定性研究。
BMJ Open. 2019 Apr 14;9(4):e028122. doi: 10.1136/bmjopen-2018-028122.
6
Understanding the adoption and use of point-of-care tests in Dutch general practices using multi-criteria decision analysis.使用多准则决策分析理解荷兰一般实践中即时检测的采用和使用。
BMC Fam Pract. 2019 Jan 10;20(1):8. doi: 10.1186/s12875-018-0893-4.
本文引用的文献
1
Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria.八种血红蛋白 A1c 即时检测仪器中有六种不符合普遍接受的分析性能标准。
Clin Chem. 2010 Jan;56(1):44-52. doi: 10.1373/clinchem.2009.130641. Epub 2009 Nov 19.
2
Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial.即时检验用于慢性病治疗控制的有效性：来自全科医疗即时检验试验的结果。
Med J Aust. 2009 Jun 1;190(11):624-6. doi: 10.5694/j.1326-5377.2009.tb02590.x.
3
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study.1989 - 2003年欧洲儿童1型糖尿病发病率趋势及2005 - 2020年预测新发病例：一项多中心前瞻性登记研究
Lancet. 2009 Jun 13;373(9680):2027-33. doi: 10.1016/S0140-6736(09)60568-7. Epub 2009 May 27.
4
Screening for type 2 diabetes: literature review and economic modelling.2型糖尿病筛查：文献综述与经济建模
Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. doi: 10.3310/hta11170.
5
Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction.基层医疗中2型糖尿病患者糖化血红蛋白的床旁检测：可接受性与满意度
Diabet Med. 2007 Jul;24(7):792-5. doi: 10.1111/j.1464-5491.2007.02175.x. Epub 2007 Apr 19.
6
Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus.2型糖尿病患者糖化血红蛋白即时检测的随机对照试验
Br J Gen Pract. 2006 Jul;56(528):511-7.
7
Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.基础胰岛素主动滴定与常规算法滴定以及即时检测糖化血红蛋白（HbA1c）与实验室检测对2型糖尿病患者血糖控制的影响：即时检测算法与实验室糖化血红蛋白血糖优化（GOAL A1C）试验
Diabetes Care. 2006 Jan;29(1):1-8. doi: 10.2337/diacare.29.01.06.dc05-1058.
8
Rapid A1c availability improves clinical decision-making in an urban primary care clinic.快速获取糖化血红蛋白（A1c）结果有助于改善城市基层医疗诊所的临床决策。
Diabetes Care. 2003 Apr;26(4):1158-63. doi: 10.2337/diacare.26.4.1158.
9
Near patient testing in diabetes clinics: appraising the costs and outcomes.
Health Technol Assess. 1999;3(15):1-74.
10
Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.糖化血红蛋白（HbA1c）水平的即时反馈可改善1型糖尿病患者和接受胰岛素治疗的2型糖尿病患者的血糖控制。
Diabetes Care. 1999 Nov;22(11):1785-9. doi: 10.2337/diacare.22.11.1785.
Zotero 插件